0001144204-18-034653.txt : 20180618
0001144204-18-034653.hdr.sgml : 20180618
20180618181459
ACCESSION NUMBER: 0001144204-18-034653
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180614
FILED AS OF DATE: 20180618
DATE AS OF CHANGE: 20180618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Capponi Vincent
CENTRAL INDEX KEY: 0001368151
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36792
FILM NUMBER: 18905636
MAIL ADDRESS:
STREET 1: MEDASORB TECHNOLOGIES
STREET 2: 7 DEER PARK DRIVE, SUITE K
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cytosorbents Corp
CENTRAL INDEX KEY: 0001175151
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 980373793
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7 DEER PARK DRIVE, SUITE K
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
BUSINESS PHONE: 973-329-8885
MAIL ADDRESS:
STREET 1: 7 DEER PARK DRIVE, SUITE K
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
FORMER COMPANY:
FORMER CONFORMED NAME: MedaSorb Technologies CORP
DATE OF NAME CHANGE: 20060807
FORMER COMPANY:
FORMER CONFORMED NAME: GILDER ENTERPRISES INC
DATE OF NAME CHANGE: 20020611
4
1
tv496714_4.xml
FORM 4
X0306
4
2018-06-14
0
0001175151
Cytosorbents Corp
CTSO
0001368151
Capponi Vincent
C/O CYTOSORBENTS CORPORATION
7 DEER PARK DRIVE, SUITE K
MONMOUTH JUNCTION
NJ
08852
0
1
0
0
Chief Operating Officer
Common Stock
2018-06-14
4
M
0
11367
3.75
A
319350
D
Common Stock
2018-06-15
4
M
0
8633
3.75
A
327983
D
Common Stock
2018-06-15
4
M
0
40000
0.875
A
367983
D
Common Stock
2018-06-14
4
S
0
11367
12.00
D
356616
D
Common Stock
2018-06-15
4
S
0
8633
12.00
D
347983
D
Common Stock
2018-06-15
4
F
0
15215
12.35
D
332768
D
Stock Option (right to buy)
3.45
2018-06-14
4
M
0
11367
0
D
2010-05-05
2020-05-05
Common Stock
11367
69933
D
Stock Option (Right to Buy)
3.45
2018-06-15
4
M
0
8633
0
D
2010-05-05
2020-05-05
Common Stock
8633
61300
D
Stock Option (Right to Buy)
0.875
2018-06-15
4
M
0
40000
0
D
2011-06-25
2018-06-25
Common Stock
40000
0
D
Stock option exercise and open market sale conducted pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Includes (i) the following RSUs that will be settled into common stock upon vesting upon a "Change In Control" of the Company: (a) 17,900 RSUs granted on February 24, 2017, (b) 54,000 RSUs granted on June 7, 2016, (c) 125,000 RSUs granted on April 8, 2015 and (d) 10,100 RSUs granted on March 15, 2018 and reported on this Form 4, (ii) the following RSUs subject to vesting as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting: (a) 11,980 of the RSUs granted to the reporting person on February 24, 2017 and unvested as of the date hereof, and (b) 25,334 RSUs granted on February 28, 2018 and unvested as of the date hereof and (iii) 88,454 shares of common stock owned by the reporting person.
These stock options vested at the discretion of the Company's Board of Directors based on satisfying certain criteria including a timely completion of the sepsis trial, raising capital for the Company, and partnering and business development. The options did not vest on May 5, 2010.
/s/ Vincent Capponi
2018-06-18